68P Phase II results of ivonescimab (ivo) a novel PD-1/VEGF bispecific in combination with chemotherapy for first-line treatment of patients (pts) with advanced/metastatic squamous (Sq) non-small cell lung cancer (NSCLC)

Authors:
  • LZL. Zhang
    L. Zhang
  • WFW.F. Fang
    W.F. Fang
  • YZY. Zhao
    Y. Zhao
  • YYY. Yang
    Y. Yang
  • NZN. Zhou
    N. Zhou
  • LCL. Chen
    L. Chen
  • YHY. Huang
    Y. Huang
  • JCJ. Chen
    J. Chen
  • LZL. Zhuang
    L. Zhuang
  • YDY. Du
    Y. Du
  • QYQ. Yu
    Q. Yu
  • WZW. Zhuang
    W. Zhuang

Abstract
No abstract available